TOP NEWS

GoodRx Sets IPO Pricing Range

Santa Monica-based GoodRx, a developer of a digital healthcare and prescriptions service, has set an IPO pricing range of between $24.00 and $28.00 per share. The company is looking to raise as much as $1.1 billion through its IPO on the NASDAQ Global Select Market. GoodRx has filed to trade as GDRX. According to the company, it is looking to sell 39,807,691 shares of its common stock in the IPO. The IPO is being underwritten by Morgan Stanley, Goldman Sachs & Co. LLC, J.P. Morgan and Barclays, along with BofA Securities, Citigroup, Credit Suisse Securities (USA) LLC, RBC Capital Markets, UBS Investment Bank, Cowen, Deutsche Bank Securities, and Evercore ISI, plus Citizens Capital Markets, KKR Capital Markets, LionTree Advisors, Raymond James, SVB Leerink, Academy Securities, Loop Capital Markets, R. Seelaus & Co., LLC and Ramirez & Co., Inc. GoodRx is backed by private equity firms Silver Lake, Francisco Partners, Spectrum, and Idea Men LLC.